Appointments: New CEOs For Lundbeck, Voyager & Neos, CSOs For iTeos & Tilos
Executive Summary
Deborah Dunsire’s appointment to lead Lundbeck tops this week’s list of new hires; Astellas, Orchard Therapeutics, Voyager Therapeutics, iTeos Therapeutics, Cevec Pharmaceuticals, Sangamo Therapeutics, Cedilla Therapeutics, Tilos Therepautics and Neos Therapeutics have also appointed new executives and directors.
You may also be interested in...
Pipeline Watch: 18 New Approvals Plus 14 Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move Renovacor Clover Biopharmaceuticals and More
Recent executive moves in the industry include C-suite changes at Renovacor and Acer Therapeutics. Meanwhile, new directors were appointed at Clover Pharmaceuticals and Chemomab Therapeutics, among others.
Pipeline Watch: Phase III EHA Trial Updates And Nine Approvals
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.